ARTICLE | Company News
NIH, KannaLife Sciences deal
September 1, 2014 7:00 AM UTC
KannaLife said NIH granted the company a license to develop and commercialize U.S. Patent No. 6,630,507, which covers cannabinoid- and cannabidiol-based therapeutics as antioxidants and neuroprotectan...